why colostrum

Diarrheal diseases are a leading cause of death and resulting malnutrition globally.

Hospital associated diarrheal conditions also contribute to poor health outcomes. Rotavirus is a leading cause of diarrhea deaths, followed by Shigella and Salmonella. Among children under 5 years old, the three aetiologies responsible for the most deaths were rotavirus, Cryptosporidium, and Shigella. Diarrheal disease aetiology separate from overall diarrheal mortality includes enteric adenovirus, Aeromaons, Entamoeba histolytica (amoebiasis), Campylobacter enteritis (Campylobacter), cryptosporidiosis (Cryptosporidium), typical enteropathogenic Escherichia coli (tEPEC), enterotoxigenic E coli (ETEC; both ST and LT), norovirus, non-typhoidal Salmonella, rotaviral enteritis (rotavirus), shigellosis (Shigella) and Vibrio cholerae. The leading risk factors for diarrhea include: unsafe water, sanitation and hygiene which in turn may result in serious malnutrition syndromes.

Lifelong risk

Antibiotic use is detrimental for long term outcomes Exposure to antibiotics early in life, maternally or via the food chain, can have a large effect on gut microbiota, disturbing its composition and functionality, which in turn can disrupt gut barrier function and lead to influx bacterial fragments into blood. As a result, low-grade chronic inflammation and metabolic endotoxemia are produced, affecting host metabolism and insulin resistance. This microbiota alteration in early life has long-lasting effects on bodyweight in adulthood; epidemiological studies have shown that early exposure to antibiotics is associated with an increased risk of obesity and metabolic disorders later in life. Those microbiota bacteria are important for body homeostasis, by participating in the digestive process, energy regulation, SCFA production, vitamin synthesis, protection against pathogenic microorganisms, and modulation of the immunologic system.


Diarrheal resultant conditions may include endotoxemia and hemolytic uremic syndrome. Endotoxemia is a critical component in the development of hemolytic uremic syndrome. Since this condition is caused by the ingestion of E. coli strains that express both a toxin (Shiga-like toxin 2) and LPS, oral administration of colostrum will treat and ameliorate the disease.

Bovine colostrum ameliorates diarrhea in infection with diarrheogenic E. coli, Shiga toxin-producing E. coli and E. coli expressing intimin and hemolysin, it supports wound healing and also the regeneration of damaged intestinal mucosa.

more benefits

  • Bovine colostrum increases colonization of probiotics 52 fold including bifido.

  • Adhesion of pathogens reduced
  • Bovine colostrum results in increased phagocytosis and reduced bacterial and viral load in 24 hours independent of immune factors
  • Antibodies against endotoxins are also contained in the natural spectrum of antibodies from bovine colostrum.

probiotics & prebiotics

Probiotics in combination with pre-biotics have become an important means of preventing and treating disease. Several types of diarrhea have been successfully treated with probiotics.

Research to fully realize this potential must focus on the following areas: 

• the identification of strains of Bifidobacterium and Lactobacillus that can withstand passage through the gastrointestinal tract 

• the identification of probiotic species and strains that are effective against specific disease processes or for the prevention of disease • the investigation of mechanisms of probiotic action 

• the identification of additional compounds that will enhance the growth of probiotic organisms (eg, the development of more effective and safer pre-biotics and selection or development of strains that will adhere to the intestinal mucosal cells.

Some related, though non-diarrheal, situations involving the effects of probiotics on bacterial overgrowth.

In patients with chronic kidney failure, there is often a bacterial overgrowth in the small intestine, resulting in toxins. These toxic compounds were significantly lower in patients treated with 2 strains of Lactobacillus acidophilus, resulting in a significantly better quality of life. Of public health importance, Campylobacter jejuni shedding in broiler chicks was all but eliminated by the administration of L. acidophilus. C. jejuni is often the cause of food poisoning in humans.

other pre-biotics

Lactulose has been used clinically to provide symptomatic relief in severe liver disease. Specifically, it lowers blood ammonia concentrations and prevents the development of hepatic encephalopathy. Because bifidobacteria and other colonic organisms metabolize lactulose, colonic contents become acidic, converting NH3 to NH4+, which serves to draw the NH3 from the blood to the colon. NH4+ is then excreted in the feces. Subjects receiving fructooligosaccharides or inulin per day had higher hydrogen and methane outputs in their breath than did subjects fed sucrose. Fecal shortchain fatty acid concentrations (eg, acetic, propionic, and butyric acids) did not change significantly. Raffinose ingestion, a naturally occurring sugar consisting of one molecule each of glucose, galactose, and fructose, resulted in a decrease in fecal pH, an increase in the short-chain fatty acid content, and an increase in Lactobacillus ssp. counts.


date nut muffins

Date Nut Muffins are a classic British teatime treat made with sweet dates and toasted walnuts.

Date nut muffins are a handy variation on date nut bread, which originated in Great Britain (specifically Scotland) as a tea time treat. This recipe uses a small amount of brown sugar.

Recipe link

Millennium Development Goal Malnutrition is the leading cause of death worldwide in children under the age of five, and is the focus of the first World Health Organization (WHO) Millennium Development Goal.

In outlining this goal the WHO established:

• breastfeeding

• food

• and water security

are major protective factors against malnutrition and critical factors in the maturation of healthy gut microbiota. A formation characterized by a transient bifidobacterial bloom before a global rise in anaerobes. Early depletion in gut Bifidobacterium longum, a typical maternal probiotic, known to inhibit pathogens, represents the first step in gut microbiota alteration associated with severe acute malnutrition (SAM). Later, the absence of the healthy mature anaerobic gut microbiota leads to:

• deficient energy harvest,

• deficient vitamin biosynthesis • deficient immune protection,

• and is associated with diarrhea,

• malabsorption

• and systemic invasion by microbial pathogens.

They went on to publish that a therapeutic diet and infection treatment may be unable to restore bifidobacteria and healthy mature microbiota. They determined as part of this goal that apart from re-feeding and antibiotics, future trials including non-toxic missing microbes and nutrients necessary to restore bifidobacteria and healthy mature microbiota, including prebiotics and antioxidants, are warranted.

Observations suggest that bovine-derived colostrum preparations deliver biologically active concentrations of specific antibodies to the intestinal lumen when taken orally, and might be capable of blocking various forms of bacterial toxins in the gut by that mechanism. Since microbial translocation is driving immune activation and progression of liver disease, strategies that reduce or prevent microbial translocation may have a significant impact on immune activation, and thus on the natural history of chronic Hepatitis C Virus infection. The present invention now demonstrates the use of bovine colostrum powder (BPC) preparations from immunized cows, containing high levels of antibodies, as immunomodulators capable of reducing immune activation in response to microbial products such as LPS.

Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron’s technology platform is capable of developing and producing an orally stable therapeutic as a potential ‘oral targeted therapy’ for various immune mediated and inflammatory disorders, among them: non-alcoholic steatohepatitis (NASH) diabetes, colitis, inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), liver fibrosis and other chronic disorders in which the immune system plays a key role in pathogenesis. These disorders represent areas of growing and unmet medical need, where oral targeted therapy drugs could offer significant advantages due to the lack of absorption and the high safety profile.

Remember, no more than 6 teaspoons (25 grams) of added sugar per day for women and 9 teaspoons (38 grams) for men. The AHA limits for children vary depending on their age and caloric needs, but range between 3-6 teaspoons (12 – 25 grams) per day. Children under two should have zero grams of sugar per day.

If you like natural health tips like the ones above you can learn more in Immune For Life